FGFR1 rearranged hematological neoplasms - molecularly defined and clinically heterogeneous

被引：7

作者：

Patnaik, Mrinal M. ^{[1
]}

Ketterling, Rhett P. ^{[2
]}

Tefferi, Ayalew ^{[1
]}

机构：

[1] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA

来源：

LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 07期

关键词：

LEUKEMIA; FAMILY;

D O I：

10.1080/10428194.2018.1429607

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1520 / 1522

页数：3

共 50 条

[21] Lack of sustained response to ponatinib treatment in myeloproliferative neoplasms associated with FGFR1 fusion genes
Kreil, S.
Ades, L.
Bommer, M.
Stegelmann, F.
Ethell, M. E.
Lubking, A.
Martin, P.
Eigendorff, E.
Hofmann, W. -K
Cross, N. C. P.
Hochhaus, A.
Reiter, A.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 151 - 151
[22] FGFR1 Internal Tandem Duplication in Histologically Defined Rosette-forming Glioneuronal Tumor
Gilani, Ahmed
Kleinschmidt-DeMasters, B. K.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 589 - 589
[23] Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement
Umino, Kento
Fujiwara, Shin-ichiro
Ikeda, Takashi
Toda, Yumiko
Ito, Shoko
Mashima, Kiyomi
Minakata, Daisuke
Nakano, Hirofumi
Yamasaki, Ryoko
Kawasaki, Yasufumi
Sugimoto, Miyuki
Yamamoto, Chihiro
Ashizawa, Masahiro
Hatano, Kaoru
Sato, Kazuya
Oh, Iekuni
Ohmine, Ken
Muroi, Kazuo
Kanda, Yoshinobu
HEMATOLOGY, 2018, 23 (08) : 470 - 477
[24] Submicroscopic Deletion of FGFR1 Gene Is Recurrently Detected in Myeloid and Lymphoid Neoplasms Associated with ZMYM2-FGFR1 Rearrangements: A Case Study
Yang, John Jeongseok
Park, Tae Sung
Choi, Jong Rak
Park, Seo-Jin
Cho, Sun Young
Jun, Kyung Ran
Kim, Hye Ran
Lee, Jeong Nyeo
Oh, Seung Hwan
Lee, Sanggyu
Kim, Bomi
Marschalek, Rolf
Meyer, Claus
ACTA HAEMATOLOGICA, 2012, 127 (02) : 119 - 123
[25] A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1)
Gotlib, Jason
Kiladjian, Jean-Jacques
Vannucchi, Alessandro
Rambaldi, Alessandro
Reiter, Andreas
Shomali, William
George, Tracy I.
Patel, Jay L.
Colucci, Philomena
Walker, Chris
Zhen, Huiling
Verstovsek, Srdan
BLOOD, 2021, 138
[26] Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
Pozdnyakova, Olga
Orazi, Attilio
Kelemen, Katalin
King, Rebecca
Reichard, Kaaren K.
Craig, Fiona E.
Quintanilla-Martinez, Leticia
Rimsza, Lisa
George, Tracy, I
Horny, Hans-Peter
Wang, Sa A.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (02) : 160 - 178
[27] Clinicopathologic Study of Myeloid/Lymphoid Neoplasms with Altered PDGFRA, PGDFRB, FGFR1 and PCM1-JAK2
Aqil, Barina
Sukhanova, Madina
Jennings, Lawrence
Lu, Xinyan
Chen, Yi-Hua
Gao, Juehua
LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 804 - 805
[28] FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms
Warmke, Laura M.
Al-Ibraheemi, Alyaa
Wang, Larry
Parham, David
Rudzinski, Erin R.
Stohr, Bradley A.
Miles, Carina
Habeeb, Omar
Davis, Jessica L.
GENES CHROMOSOMES & CANCER, 2023, 62 (11): : 641 - 647
[29] Clinicopathologic Study of Myeloid/Lymphoid Neoplasms with Altered PDGFRA, PGDFRB, FGFR1 and PCM1-JAK2
Aqil, Barina
Sukhanova, Madina
Jennings, Lawrence
Lu, Xinyan
Chen, Yi-Hua
Gao, Juehua
MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 804 - 805
[30] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
Simone Romagnoli
Niccolò Bartalucci
Francesca Gesullo
Manjola Balliu
Stefania Bonifacio
Anair Graciela Lema Fernandez
Francesco Mannelli
Davide Bolognini
Elisabetta Pelo
Cristina Mecucci
Paola Guglielmelli
Alessandro Maria Vannucchi
Biomarker Research, 9

← 1 2 3 4 5 →